235 studies found for:    Open Studies | "Urinary Bladder Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I
Conditions: Urinary Bladder Neoplasms;   Urologic Neoplasms;   Urogenital Neoplasms;   Neoplasms;   Neoplasms by Site;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Device: Synergo + MMC;   Drug: Bacillus Calmette-Guérin
2 Recruiting A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Conditions: Overactive Bladder;   Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: mirabegron;   Drug: antimuscarinic medication
3 Recruiting A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Intervention: Drug: Betmiga®
4 Recruiting This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases\Urologic Diseases
Interventions: Drug: Solifenacin Succinate;   Drug: Mirabegron;   Drug: Placebo
5 Not yet recruiting 3D HD Versus 2D HD in Cholecystectomy
Conditions: Cholelithiasis;   Gall Bladder Disease
Interventions: Device: 3D HD laparoscopy;   Device: 2D HD laparoscopy
6 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
7 Unknown  Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Condition: Bladder Exstrophy
Intervention:
8 Recruiting Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Conditions: Bladder Cancer;   Carcinoma, Transitional Cell;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Enzalutamide;   Drug: Cisplatin;   Drug: Gemcitabine
9 Recruiting Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC
Condition: Carcinoma of Urinary Bladder, Superficial
Interventions: Device: 40 mg MMC gel;   Other: Standard of care MMC mixed with water;   Device: 80 mg MMC gel
10 Recruiting CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children
Condition: Vesico-Ureteral Reflux
Intervention: Drug: OPTISON
11 Unknown  Tamoxifen in Treating Patients With Metastatic Bladder Cancer That Did Not Respond to Previous Chemotherapy
Condition: Bladder Cancer
Interventions: Drug: tamoxifen citrate;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
12 Unknown  Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Conditions: Chronic Prostatitis (CP);   Chronic Pelvic Pain Syndrome (CPPS);   Painful Bladder Syndrome (PBS);   Benign Frequency Syndrome (BFS);   Benign Daytime Frequency Syndrome (BDFS)
Intervention:
13 Recruiting Transvaginal Treatment of Symptomatic Cystocele Grade II-III
Condition: Cystocele
Intervention: Device: cystocele repair with biomesh soft prolaps and endofast reliant
14 Unknown  Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder
Condition: Overactive Bladder
Intervention: Behavioral: Health education intervention (HEI)
15 Recruiting Bladder Thermal Distention for Patients With Interstitial Cystitis / Painful Bladder Syndrome
Conditions: Interstitial Cystitis;   Painful Bladder Syndrome
Intervention: Procedure: Bladder Thermal Distention
16 Recruiting Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients
Condition: Overactive Bladder Syndrome
Interventions: Drug: Solifenacin for 12 weeks;   Drug: Solifenacin for 24 weeks
17 Recruiting Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study)
Condition: Bladder Cancer
Interventions: Drug: Bacille Calmette-Guerin;   Drug: uracil-tegafur
18 Recruiting Supraspinal Control of Lower Urinary Tract Function in Healthy Controls & Patients With Bladder Dysfunction
Conditions: Neurogenic Lower Urinary Tract Dysfunction;   Multiple Sclerosis;   Overactive Bladder;   Spinal Cord Injury
Interventions: Other: fMRI;   Other: bladder filling;   Other: bladder cooling;   Other: additional post-treatment fMRI scan
19 Recruiting Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy
Condition: Bladder Cancer
Intervention:
20 Recruiting Chronic Pain Risk Associated With Menstrual Period Pain
Conditions: Cystitis, Interstitial;   Dysmenorrhea;   Migraine Disorders;   Pelvic Pain;   Endometriosis;   Visceral Pain
Intervention: Drug: microgestin 1/20

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years